Physician profile
Amanda Monteleone
NPI 1003166984
$2,554.58
in general payments reported to CMS, 2019-2025
16 companies · $658 in 2025
The $658 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.97 · 2021: $88.78 · 2022: $168 · 2023: $739 · 2024: $862 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809 · Travel and Lodging: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,808.55 |
| Travel and Lodging | $450.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $450.36 | 2024 | Carto 3 |
| Boston Scientific Corporation | $424.82 | 2023-2025 | Bodyguardian, Watchman Access System, Watchman Flx |
| Abbott Laboratories | $384.56 | 2021-2023 | Ensite, Aveir, Amplatzer Amulet |
| Medtronic, INC. | $324.18 | 2021-2025 | Linq II, Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $278.16 | 2023-2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $226.72 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.94 | 2020-2025 | Lifevest |
| Heartflow, INC. | $64.01 | 2025 | |
| Esperion Therapeutics, INC. | $58.57 | 2025 | Nexletol |
| Abiomed | $40.34 | 2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $36.75 | 2025 | Camzyos |
| Pfizer INC. | $32.45 | 2024 | |
| Edwards Lifesciences Corporation | $31.38 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Scpharmaceuticals INC. | $21.60 | 2025 | |
| Cvrx, INC. | $18.68 | 2025 | Barostim Neo System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Monteleone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.